dual IDO checkpoint inhibitor/TDO checkpoint inhibitor (Idorsia Pharmaceuticals)

N/A

Report date: 2025/06/11 11:17:47
NME

Base Information

Drug Namedual IDO checkpoint inhibitor/TDO checkpoint inhibitor (Idorsia Pharmaceuticals)
Drug Alias Namedual IDO1/TDO2 inhibitors (Idorsia Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsImmunostimulantsT lymphocytes stimulants +[4] 
TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIdorsia Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A